Carroll Financial Associates’s Adient ADNT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADNT
LAM
N
Carroll Financial Associates's ADNT Position: Q4 2021 in Review
Carroll Financial Associates increased its Adient (ADNT) stake by 57% in Q4 2021, buying an estimated $718 and bringing the position to 44 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1468.
Carroll Financial Associates first reported a position in ADNT in Q1 2017 and has held it in 20 quarters since. The position peaked at $42K in Q1 2017. 285 funds tracked by Wall St. Rank hold ADNT as of Q4 2021.
- Carroll Financial Associates held 44 shares of Adient worth $2K as of Q4 2021.
- Carroll Financial Associates bought 16 Adient shares in Q4 2021, an estimated $718.
- Adient made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #1468 holding.
- Carroll Financial Associates first reported a position in Adient in Q1 2017 and has held it in 20 quarters since.
- Carroll Financial Associates's Adient position peaked at $42K in Q1 2017.
- 285 funds tracked by Wall St. Rank held Adient as of Q4 2021.
Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.